Welcome to CSNpharm! For Research Use Only!
c-FMS
| Cat. No. | Product Name | CAS No. | Information |
|---|---|---|---|
| CSN24725 | PLX5622 | 1303420-67-8 | PLX5622 is a highly selective brain-penetrant CSF1R inhibitor allowing for extended and specific microglial elimination, preceding and during pathology development. |
| CSN17212 | Pexidartinib | 1029044-16-3 | Pexidartinib is a small-molecule receptor tyrosine kinase RTK inhibitor of KIT CSF1R and FLT3 with IC50s of 20 10 and 160 nM in vitro respectively |
| CSN12340 | Pazopanib | 444731-52-6 | Pazopanib is a multi-target inhibitor of VEGFR1 VEGFR2 VEGFR3 PDGFR FGFR c-Kit and c-Fms with IC50 of 10 nM 30 nM 47 nM 84 nM 74 nM 140 nM and 146 nM respectively |
| CSN12402 | Linifanib | 796967-16-3 | Linifanib is a potent ATP-competitive VEGFRPDGFR inhibitor for KDR, CSF-1R, Flt-13 and PDGFR with IC50 of 4 nM, 3 nM, 3 nM4 nM and 66 nM respectively. |
| CSN16124 | Ki20227 | 623142-96-1 | Ki-20227 is a highly selective c-Fms tyrosine kinase (CSF1R) inhibitor with IC50 value of 2 nM, displaying 6 fold and 100 fold selectivity over VEGFR2 (IC5012 nM) and c-KitPDGFR (IC50451217 nM), respectively. |
| CSN19706 | Edicotinib | 1142363-52-7 | JNJ-40346527 is an orally available inhibitor of colony-stimulating factor-1 receptor (CSF1R) with potential antineoplastic activity. |
| CSN12714 | GW2580 | 870483-87-7 | GW2580 is a selective CSF-1R inhibitor for c-FMS with IC50 of 30 nM, 150- to 500-fold selective compared to b-Raf, CDK4, c-KIT, c-SRC, EGFR, ERBB24, ERK2, FLT-3, GSK3, ITK, JAK2 etc. |
| CSN21196 | GENZ-882706 | 2070864-35-4 | GENZ-882706 is a potent colony stimulating factor-1 receptor (CSF-1R) inhibitor that intends to treat immune-mediated diseases and neurological diseases. |
| CSN24802 | BPR1K871 | 2443767-35-7 | DBPR114 is a potent multi-kinase inhibitor with potent activities against more than 57 oncogenic kinases, including Aurora-A, FLT3, CSF1R, MET, etc. DBPR114 exhibited favorable PK profiles: a long half-life (t1/2 = 23.5 h), moderate clearance and high volume of distribution. Also DBPR114 can effectively inhibit the growth of human acute myeloid leukemia MOLM-13 and MV4-11, MIA PaCa-2, Hep3B, MKN45, Colo205, and NTUB1 solid tumor xenografts in vivo without causing significant body weight loss. |
| CSN24083 | cFMS Receptor Inhibitor II | 959860-85-6 | cFMS Receptor Inhibitor II is a cFMS inhibitor. |
| CSN13574 | c-Fms-IN-3 | 885704-21-2 | c-FMS inhibitor is a c-Fms kinase inhibitor with a potential as anti-inflammatory agent and antirheumatic agent. |
| CSN15751 | Sotuletinib | 953769-46-5 | BLZ945 is a highly selective and brain-penetrant inhibitor of CSF1R with IC50 of 1 nM and 3200-fold higher than its affinity for other kinases |
| CSN22609 | AZ304 | 942507-42-8 | AZ304 is an inhibitor of BRAF and can target many kinases The IC50s for wild type BRAF V600E mutant BRAF and wild type CRAF are 79 nM 38 nM and 68 nM respectively It can also inhibit p38 IC50 6 nM and CSF1R IC50 35 nM |
+1-708-781-1677
+1-708-286-6026
sales@csnpharm.com
